Member Info for maximillion69

.Frankly its very worrying that insiders with very material involvement in the success or otherwise of the business, wouldn't have explored all the obvious options in great detail over the years . Id imagine they have why else develop and keep developing the technology .

semantic ,

With maybe 2 drug trials in the pipe line how are IBAI going to finance ? RNS suggestions CLN's can you discuss ? Is it preferential for the CLN investor to have a lower Share price ?

Max

“exemplifies your hypothesis that it is spades of publicity which makes for success”

An assumption !!

Where do other companies come into this ?

Please do your research and look into all the RNS

Publicising what May develop here when the time suits !

“is an example of an ad hominem attack”. That’s a totally hypocritical response .

I mean no man harm !

Semantic

You’re constantly attacking share holders please reason why ?

Why do you not want an increase in SP we would all sit easier ?

Long term holders will stay invested whatever traders do please identify the difference

Targeting is key, I would suggest an RNS is not going to be read by a single oncologist

No need for a RNS not asking for that .

LinkedIn would be read by other professionals

and maybe other shareholders not on here

Why wouldn’t they publicise this ?

It’s in the public domain !

Why leave it for another to post on social media ?

We know your busy, but put a Xpost or LinkedIn post let your shareholders know your thinking of them as you suggested in the RNS

Sound Trek

You say it much better than me 👍

Max

They’re both on Oxford press Tyke

https://academic.oup.com/neuro-onc-peds/article/1/Supplement_1/wuaf001.100/8231139

Shrek is back in Town !!

Nice find , how far away from announcing Phase1 paediatric trail ?

https://academic.oup.com/neuro-onc-peds/article/1/Supplement_1/wuaf001.301/8231165

Https://www.linkedin.com/posts/glioblastoma-research-organization_gbmdefine-glioblastoma-braintumorawareness-activity-7362869110138904576-_d7B?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://www.linkedin.com/posts/asfnr_asfnr25-beyondbold-activity-7353793572518658049-gKrh?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://www.linkedin.com/posts/andrew-nencka_challenges-and-opportunities-for-advancing-activity-7362126211071815681-EaMU?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Thanks Kane .

Https://virtualtrials.org/pdf2022/imaging.pdf

This looks neat ,can’t work out if it’s new imaging , any body seen before ?

Https://x.com/imgbiometrics/status/1956028335147921886?s=46

Thanks Red

Yes worked out well, RNS mentions TB and his CLN , Semantic’s last post suggests TB’s age being the reason sold to BRH for protection , could BRH issue CLN ?

Can I also ask if you have been selling of late ?

Hi Red

Thanks for sharing , any reason for your optimism

Max .

Https://www.linkedin.com/posts/towards-healthcare_glioblastoma-research-organization-attracts-activity-7358851909559963652-5REk?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://www.biospace.com/drug-development/glioblastoma-funding-rises-as-nonprofits-drive-interest-and-pharma-returns-to-the-table